Christopher J. Fisher

Associate

fisher-christopher-300
  • JD, magna cum laude; Order of the Coif, DePaul University College of Law, 2012; Business Law Certificate
  • BA (Business Administration, Investment Finance), The Ohio State University, 2006

Qualifications

  • Illinois, 2012

Christopher J. Fisher

Associate

Christopher Fisher focuses his practice primarily on transactional matters, representing private equity firms and strategic investors in the structuring and negotiation of leveraged buyouts, cross-border transactions, public and private mergers, acquisitions and divestitures and other general corporate matters.

Prior to joining Ropes & Gray, Christopher was an associate in Jenner & Block’s corporate practice, focusing on mergers & acquisitions, debt and equity securities offerings and other financial transactions. Previous to beginning his legal practice, Christopher worked in various capacities for LaSalle Bank and Bank of America. Christopher’s banking experience includes, but is not limited to, structured finance, operations management and project management.

Experience

  • Represented Baring Private Equity Asia in its investment in the acquisition of Thomson Reuters’ Intellectual Property & Science Business.
  • Represented HealthSouth Corporation in its acquisition of CareSouth Health System Inc., a private provider of home health services.
  • Represented GHO Capital in its acquisition of DNA Diagnostics Centers.
  • Represented BV Investment Partners in its investment in Critical Mix.
  • Represented BV Investment Partners in its investment in C-4 Analytics.
  • Represented Pfingsten Partners in its sale of Technibus Inc.

Notable transactions in which Chris was involved prior to joining the firm include:

  • Representation of one of the world’s largest agri-businesses in its US$1.3 billion dollar blended stock and asset acquisition of its global cocoa business by an industry competitor.
  • Representation of one of the world’s largest agri-businesses in its US$440 million dollar blended stock and asset acquisition of its global chocolate business by an industry competitor.
  • Representation of Obagi Medical Products in its US$441 million public company cash tender acquisition by Valeant Pharmaceuticals International Inc.
  • Representation of Merge Healthcare Inc. in its cash tender offer for all of its US$252 million outstanding 11.75% Senior Secured Notes and related entry into a US$275 million Term and Revolving Loan Credit Facility.
  • Representation of industry leading private aerospace firm in its US$40 million dollar security services agreement.
  • Representation of General Motors Company in its US$1.7 billion dollar secondary offering of common stock held by the United States Department of Treasury and the UAW Retiree Medical Benefits Trust.
  • Representation of General Motors Company in a US$175 million public secondary offering of warrants to purchase GM common stock by a UAW VEBA trust through a modified “Dutch auction” process.
  • Representation of General Motors Company in its US$4.5 billion dollar private placement of senior notes, and its corresponding US$4.5 billion dollar A/B Exchange.

Publications

  • Co-Author – “Proposed Delaware Amendment May Increase Use of Tender-Offer Structures,” VC Experts (October 2013)
Cookie Settings